Home > Press Releases > Gut Microbiome Market

Gut Microbiome Market Likely to Surpass USD 5.1 Billion by 2035

Report Code: FB-37202  |  Published in: Sep 2026, By MarketGenics  |  Number of pages: 317
Get PDF
Buy

Global Gut Microbiome Market Forecast 2035:

According to the report, the global gut microbiome market is likely to grow from USD 1.7 Billion in 2025 to USD 5.1 Billion in 2035 at a highest CAGR of 11.6% during the time period. The gut microbiome market is transitioning from a research-driven area to a larger commercialized space where there is a growing interest in microbiome diagnostics, functional food, microbiome-based therapeutics, dietary supplement and personalised nutrition. Recent developments in sequencing, bioinformatics and microbial characterization have helped to better define specific microbial profiles and their connections to human health, thereby better supporting new microbiome-based products and services.

Healthcare / Life Sciences companies are increasingly engaging with the microbiome, which is driving greater diversification in competition as companies in the pharmaceutical, biotechnology, food, nutrition and healthcare sectors develop strain specific formulations, microbial testing platforms, microbial biomarkers, live biotherapeutic products and targeted nutritional solutions. Research partnerships and the integration of technology are also helping to drive the shift towards more scientifically defined products instead of ones that focus on general gut health.

Recognizing the gut-brain, gut-immune, gut-microbial and gut-metabolic link is expanding the use of the market beyond digestive health. This expanding understanding is attracting investments in solutions to challenges related to immunity, metabolic wellness, cognitive wellness, and chronic disease management, and the increasing clinical evidence and commercialization of microbiome-based solutions is beginning to build acceptance in the healthcare provider and consumer communities.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Gut Microbiome Market”

The microbiome market is gaining from microbiome research being translated into clinically relevant diagnostics and therapeutic interventions. As metagenomic sequencing, microbial biomarker identification and host–microbiome research continues to evolve, companies are able to create solutions for gastrointestinal, metabolic and immune conditions. Better integration of biotechnology companies, pharmaceutical companies and research institutions is guiding toward commercialization and further enhancing the clinical relevance of microbiome products.

The lack of standardization for microbial analysis, microbial taxonomies, sample handling, and product characterization presents challenges to market players. These variations in sequence methodology, analytical platforms, reference databases and interpretation protocols may lead to variation among laboratory or product results. These restrictions, in turn, make the validation process more complex, make comparisons more difficult, and could delay the commercialization of microbiome diagnostics and therapeutics.

Targeted microbiome interventions offer a tremendous opportunity for pharmaceutical and biotechnology companies to create next generation probiotics, live biotherapeutic products, defined microbial consortia, and microbiota-derived therapeutics. The growing use of microbial engineering and precision strain selection, with a focus on specific biological pathways instead of using a generic probiotic formulation, delivers higher-value use across disease prevention and treatment.

Expansion of Global Gut Microbiome Market

“Expansion of Microbiome-Based Diagnostics, Therapeutics, and Precision Health Applications”

  • Microbiome testing and sequencing platforms are increasingly being used in preventive health care and personalized nutrition, driving the growth of the gut microbiome market beyond traditional probiotics and supplements. Increasingly, companies are coming up with products that can profile the microbial makeup and functional properties to provide personalized diet, health and disease management advice, extending their commercial use beyond consumer to clinical applications.
  • Microbiome-based therapeutics are creating a new avenue for market expansion as research increasingly translates microbial discoveries into targeted interventions for gastrointestinal and other chronic conditions. With the commercialization of microbiota-based therapies and the emergence of products known as live biotherapeutic products, the addressable market for microbiota-based products is expanding past nutrition products, encouraging pharmaceutical companies and biotechnology firms to create their own microbiome pipelines.
  • Integration with precision medicine and advanced healthcare technologies such as artificial intelligence, multi-omics analysis, and biomarker discovery are also driving expansion. By elucidating the links between microbial community patterns and health outcomes, these technologies could help inform the development of more precise diagnostics and therapeutic strategies, and open up new avenues for microbiome companies in the healthcare, pharmaceutical, biotechnology and personalized wellness sectors.

Regional Analysis of Global Gut Microbiome Market

  • Advanced microbiome research infrastructure, increasing the use of probiotics, functional nutrition, high healthcare expenditure and commercialization of microbiome-based diagnostics and therapeutics are driving the North America region to the lead position in the global gut microbiome market. The U.S. has a robust biotechnology sector, significant clinical research assets, and has made significant strides in the regulatory pathway for microbiome-based interventions, with a supportive environment for innovation, product development, and clinical uptake.
  • Asia Pacific is anticipated to register the fastest growth in the gut microbiome market, owing to an increase in healthcare awareness, functional food consumption, healthcare R&D investments, and rising trend towards personalized nutrition in emerging nations. As microbiomes are a growing focus in Chinese, Japanese, South Korean, Indian and Australian research and commercialization, a greater consumer interest in digestive well-being and preventive medicine is generating significant opportunities for microbiome testing, supplements and next-generation therapeutic products.

Prominent players operating in the global gut microbiome market are Assembly Biosciences, Inc., Chr. Hansen Holding A/S, Danone S.A., Enterome, Finch Therapeutics Group, Inc., MaaT Pharma, Microbiotica Ltd., Nestlé Health Science, Novonesis A/S, Rebiotix Inc. (a Ferring Company), Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Vedanta Biosciences, Inc., Yakult Honsha Co., Ltd., Other Key Players.

The global gut microbiome market has been segmented as follows:

Global Gut Microbiome Market Analysis, by Product Type

  • Probiotics
  • Prebiotics
  • Synbiotics
  • Postbiotics
  • Live Biotherapeutic Products
  • Fecal Microbiota Transplantation Products
  • Microbiome Diagnostics
    • Sequencing-based Diagnostics
    • PCR-based Diagnostics
    • Other Diagnostic Kits
  • Microbiome-Based Medical Foods
  • Gut Health Supplements

Global Gut Microbiome Market Analysis, by Technology

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Spectroscopy
  • Chromatography
  • Flow Cytometry
  • Microarray Technology
  • Others (Metabolomics, Culturomics, etc.)

Global Gut Microbiome Market Analysis, by Application

  • Obesity & Metabolic Disorders
  • Diabetes
  • Inflammatory Bowel Disease
  • Cancer
  • Autoimmune Diseases
  • Neurological Disorders (Gut-Brain Axis)
  • Cardiovascular Diseases
  • Skin Diseases
  • Others (Allergies, Infections, etc.)

Global Gut Microbiome Market Analysis, by Route of Administration

  • Oral
  • Topical
  • Others (Rectal/Fecal Transplant-based)

Global Gut Microbiome Market Analysis, by Age Group

  • Pediatric
  • Adult
  • Geriatric

Global Gut Microbiome Market Analysis, by End User

  • Hospitals & Clinics
  • Diagnostic & Reference Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Home Care Settings

Global Gut Microbiome Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Gut Microbiome Market Outlook
      • 2.1.1. Gut Microbiome Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Food & Beverages Industry Overview, 2025
      • 3.1.1. Food & Beverages Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Food & Beverages Industry
      • 3.1.3. Regional Distribution for Food & Beverages Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising Awareness of Gut Health and Preventive Healthcare
        • 4.1.1.2. Increasing Prevalence of Gastrointestinal, Metabolic, and Chronic Diseases
        • 4.1.1.3. Growing Adoption of Personalized Nutrition and Microbiome-Based Therapies
      • 4.1.2. Restraints
        • 4.1.2.1. Regulatory Complexity and Lack of Harmonized Microbiome-Specific Guidelines
        • 4.1.2.2. High R&D and Clinical Validation Costs for Microbiome-Based Products
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Ecosystem Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Gut Microbiome Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Gut Microbiome Market Analysis, by Product Type
    • 6.1. Key Segment Analysis
    • 6.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 6.2.1. Probiotics
      • 6.2.2. Prebiotics
      • 6.2.3. Synbiotics
      • 6.2.4. Postbiotics
      • 6.2.5. Live Biotherapeutic Products
      • 6.2.6. Fecal Microbiota Transplantation Products
      • 6.2.7. Microbiome Diagnostics
        • 6.2.7.1. Sequencing-based Diagnostics
        • 6.2.7.2. PCR-based Diagnostics
        • 6.2.7.3. Other Diagnostic Kits
      • 6.2.8. Microbiome-Based Medical Foods
      • 6.2.9. Gut Health Supplements
  • 7. Global Gut Microbiome Market Analysis, by Technology
    • 7.1. Key Segment Analysis
    • 7.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 7.2.1. Next-Generation Sequencing (NGS)
      • 7.2.2. Polymerase Chain Reaction (PCR)
      • 7.2.3. Spectroscopy
      • 7.2.4. Chromatography
      • 7.2.5. Flow Cytometry
      • 7.2.6. Microarray Technology
      • 7.2.7. Others (Metabolomics, Culturomics, etc.)
  • 8. Global Gut Microbiome Market Analysis, by Application
    • 8.1. Key Segment Analysis
    • 8.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 8.2.1. Obesity & Metabolic Disorders
      • 8.2.2. Diabetes
      • 8.2.3. Inflammatory Bowel Disease
      • 8.2.4. Cancer
      • 8.2.5. Autoimmune Diseases
      • 8.2.6. Neurological Disorders (Gut-Brain Axis)
      • 8.2.7. Cardiovascular Diseases
      • 8.2.8. Skin Diseases
      • 8.2.9. Others (Allergies, Infections, etc.)
  • 9. Global Gut Microbiome Market Analysis, by Route of Administration
    • 9.1. Key Segment Analysis
    • 9.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by Route of Administration, 2021-2035
      • 9.2.1. Oral
      • 9.2.2. Topical
      • 9.2.3. Others (Rectal/Fecal Transplant-based)
  • 10. Global Gut Microbiome Market Analysis, by Age Group
    • 10.1. Key Segment Analysis
    • 10.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by Age Group, 2021-2035
      • 10.2.1. Pediatric
      • 10.2.2. Adult
      • 10.2.3. Geriatric
  • 11. Global Gut Microbiome Market Analysis, by End User
    • 11.1. Key Segment Analysis
    • 11.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 11.2.1. Hospitals & Clinics
      • 11.2.2. Diagnostic & Reference Laboratories
      • 11.2.3. Academic & Research Institutes
      • 11.2.4. Pharmaceutical & Biotechnology Companies
      • 11.2.5. Contract Research Organizations (CROs)
      • 11.2.6. Home Care Settings
  • 12. Global Gut Microbiome Market Analysis and Forecasts, by Region
    • 12.1. Key Findings
    • 12.2. Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 12.2.1. North America
      • 12.2.2. Europe
      • 12.2.3. Asia Pacific
      • 12.2.4. Middle East
      • 12.2.5. Africa
      • 12.2.6. South America
  • 13. North America Gut Microbiome Market Analysis
    • 13.1. Key Segment Analysis
    • 13.2. Regional Snapshot
    • 13.3. North America Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 13.3.1. Product Type
      • 13.3.2. Technology
      • 13.3.3. Application
      • 13.3.4. Route of Administration
      • 13.3.5. Age Group
      • 13.3.6. End User
      • 13.3.7. Country
        • 13.3.7.1. USA
        • 13.3.7.2. Canada
        • 13.3.7.3. Mexico
    • 13.4. USA Gut Microbiome Market
      • 13.4.1. Country Segmental Analysis
      • 13.4.2. Product Type
      • 13.4.3. Technology
      • 13.4.4. Application
      • 13.4.5. Route of Administration
      • 13.4.6. Age Group
      • 13.4.7. End User
    • 13.5. Canada Gut Microbiome Market
      • 13.5.1. Country Segmental Analysis
      • 13.5.2. Product Type
      • 13.5.3. Technology
      • 13.5.4. Application
      • 13.5.5. Route of Administration
      • 13.5.6. Age Group
      • 13.5.7. End User
    • 13.6. Mexico Gut Microbiome Market
      • 13.6.1. Country Segmental Analysis
      • 13.6.2. Product Type
      • 13.6.3. Technology
      • 13.6.4. Application
      • 13.6.5. Route of Administration
      • 13.6.6. Age Group
      • 13.6.7. End User
  • 14. Europe Gut Microbiome Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. Europe Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Product Type
      • 14.3.2. Technology
      • 14.3.3. Application
      • 14.3.4. Route of Administration
      • 14.3.5. Age Group
      • 14.3.6. End User
      • 14.3.7. Country
        • 14.3.7.1. Germany
        • 14.3.7.2. United Kingdom
        • 14.3.7.3. France
        • 14.3.7.4. Italy
        • 14.3.7.5. Spain
        • 14.3.7.6. Netherlands
        • 14.3.7.7. Nordic Countries
        • 14.3.7.8. Poland
        • 14.3.7.9. Russia & CIS
        • 14.3.7.10. Rest of Europe
    • 14.4. Germany Gut Microbiome Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Product Type
      • 14.4.3. Technology
      • 14.4.4. Application
      • 14.4.5. Route of Administration
      • 14.4.6. Age Group
      • 14.4.7. End User
    • 14.5. United Kingdom Gut Microbiome Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Product Type
      • 14.5.3. Technology
      • 14.5.4. Application
      • 14.5.5. Route of Administration
      • 14.5.6. Age Group
      • 14.5.7. End User
    • 14.6. France Gut Microbiome Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Product Type
      • 14.6.3. Technology
      • 14.6.4. Application
      • 14.6.5. Route of Administration
      • 14.6.6. Age Group
      • 14.6.7. End User
    • 14.7. Italy Gut Microbiome Market
      • 14.7.1. Country Segmental Analysis
      • 14.7.2. Product Type
      • 14.7.3. Technology
      • 14.7.4. Application
      • 14.7.5. Route of Administration
      • 14.7.6. Age Group
      • 14.7.7. End User
    • 14.8. Spain Gut Microbiome Market
      • 14.8.1. Country Segmental Analysis
      • 14.8.2. Product Type
      • 14.8.3. Technology
      • 14.8.4. Application
      • 14.8.5. Route of Administration
      • 14.8.6. Age Group
      • 14.8.7. End User
    • 14.9. Netherlands Gut Microbiome Market
      • 14.9.1. Country Segmental Analysis
      • 14.9.2. Product Type
      • 14.9.3. Technology
      • 14.9.4. Application
      • 14.9.5. Route of Administration
      • 14.9.6. Age Group
      • 14.9.7. End User
    • 14.10. Nordic Countries Gut Microbiome Market
      • 14.10.1. Country Segmental Analysis
      • 14.10.2. Product Type
      • 14.10.3. Technology
      • 14.10.4. Application
      • 14.10.5. Route of Administration
      • 14.10.6. Age Group
      • 14.10.7. End User
    • 14.11. Poland Gut Microbiome Market
      • 14.11.1. Country Segmental Analysis
      • 14.11.2. Product Type
      • 14.11.3. Technology
      • 14.11.4. Application
      • 14.11.5. Route of Administration
      • 14.11.6. Age Group
      • 14.11.7. End User
    • 14.12. Russia & CIS Gut Microbiome Market
      • 14.12.1. Country Segmental Analysis
      • 14.12.2. Product Type
      • 14.12.3. Technology
      • 14.12.4. Application
      • 14.12.5. Route of Administration
      • 14.12.6. Age Group
      • 14.12.7. End User
    • 14.13. Rest of Europe Gut Microbiome Market
      • 14.13.1. Country Segmental Analysis
      • 14.13.2. Product Type
      • 14.13.3. Technology
      • 14.13.4. Application
      • 14.13.5. Route of Administration
      • 14.13.6. Age Group
      • 14.13.7. End User
  • 15. Asia Pacific Gut Microbiome Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Asia Pacific Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Product Type
      • 15.3.2. Technology
      • 15.3.3. Application
      • 15.3.4. Route of Administration
      • 15.3.5. Age Group
      • 15.3.6. End User
      • 15.3.7. Country
        • 15.3.7.1. China
        • 15.3.7.2. India
        • 15.3.7.3. Japan
        • 15.3.7.4. South Korea
        • 15.3.7.5. Australia and New Zealand
        • 15.3.7.6. Indonesia
        • 15.3.7.7. Malaysia
        • 15.3.7.8. Thailand
        • 15.3.7.9. Vietnam
        • 15.3.7.10. Rest of Asia Pacific
    • 15.4. China Gut Microbiome Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Product Type
      • 15.4.3. Technology
      • 15.4.4. Application
      • 15.4.5. Route of Administration
      • 15.4.6. Age Group
      • 15.4.7. End User
    • 15.5. India Gut Microbiome Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Product Type
      • 15.5.3. Technology
      • 15.5.4. Application
      • 15.5.5. Route of Administration
      • 15.5.6. Age Group
      • 15.5.7. End User
    • 15.6. Japan Gut Microbiome Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Product Type
      • 15.6.3. Technology
      • 15.6.4. Application
      • 15.6.5. Route of Administration
      • 15.6.6. Age Group
      • 15.6.7. End User
    • 15.7. South Korea Gut Microbiome Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Product Type
      • 15.7.3. Technology
      • 15.7.4. Application
      • 15.7.5. Route of Administration
      • 15.7.6. Age Group
      • 15.7.7. End User
    • 15.8. Australia and New Zealand Gut Microbiome Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Product Type
      • 15.8.3. Technology
      • 15.8.4. Application
      • 15.8.5. Route of Administration
      • 15.8.6. Age Group
      • 15.8.7. End User
    • 15.9. Indonesia Gut Microbiome Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Product Type
      • 15.9.3. Technology
      • 15.9.4. Application
      • 15.9.5. Route of Administration
      • 15.9.6. Age Group
      • 15.9.7. End User
    • 15.10. Malaysia Gut Microbiome Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Product Type
      • 15.10.3. Technology
      • 15.10.4. Application
      • 15.10.5. Route of Administration
      • 15.10.6. Age Group
      • 15.10.7. End User
    • 15.11. Thailand Gut Microbiome Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Product Type
      • 15.11.3. Technology
      • 15.11.4. Application
      • 15.11.5. Route of Administration
      • 15.11.6. Age Group
      • 15.11.7. End User
    • 15.12. Vietnam Gut Microbiome Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Product Type
      • 15.12.3. Technology
      • 15.12.4. Application
      • 15.12.5. Route of Administration
      • 15.12.6. Age Group
      • 15.12.7. End User
    • 15.13. Rest of Asia Pacific Gut Microbiome Market
      • 15.13.1. Country Segmental Analysis
      • 15.13.2. Product Type
      • 15.13.3. Technology
      • 15.13.4. Application
      • 15.13.5. Route of Administration
      • 15.13.6. Age Group
      • 15.13.7. End User
  • 16. Middle East Gut Microbiome Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Middle East Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Product Type
      • 16.3.2. Technology
      • 16.3.3. Application
      • 16.3.4. Route of Administration
      • 16.3.5. Age Group
      • 16.3.6. End User
      • 16.3.7. Country
        • 16.3.7.1. Turkey
        • 16.3.7.2. UAE
        • 16.3.7.3. Saudi Arabia
        • 16.3.7.4. Israel
        • 16.3.7.5. Rest of Middle East
    • 16.4. Turkey Gut Microbiome Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Product Type
      • 16.4.3. Technology
      • 16.4.4. Application
      • 16.4.5. Route of Administration
      • 16.4.6. Age Group
      • 16.4.7. End User
    • 16.5. UAE Gut Microbiome Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Product Type
      • 16.5.3. Technology
      • 16.5.4. Application
      • 16.5.5. Route of Administration
      • 16.5.6. Age Group
      • 16.5.7. End User
    • 16.6. Saudi Arabia Gut Microbiome Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Product Type
      • 16.6.3. Technology
      • 16.6.4. Application
      • 16.6.5. Route of Administration
      • 16.6.6. Age Group
      • 16.6.7. End User
    • 16.7. Israel Gut Microbiome Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Product Type
      • 16.7.3. Technology
      • 16.7.4. Application
      • 16.7.5. Route of Administration
      • 16.7.6. Age Group
      • 16.7.7. End User
    • 16.8. Rest of Middle East Gut Microbiome Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Product Type
      • 16.8.3. Technology
      • 16.8.4. Application
      • 16.8.5. Route of Administration
      • 16.8.6. Age Group
      • 16.8.7. End User
  • 17. Africa Gut Microbiome Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Africa Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Product Type
      • 17.3.2. Technology
      • 17.3.3. Application
      • 17.3.4. Route of Administration
      • 17.3.5. Age Group
      • 17.3.6. End User
      • 17.3.7. Country
        • 17.3.7.1. South Africa
        • 17.3.7.2. Egypt
        • 17.3.7.3. Nigeria
        • 17.3.7.4. Algeria
        • 17.3.7.5. Rest of Africa
    • 17.4. South Africa Gut Microbiome Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Product Type
      • 17.4.3. Technology
      • 17.4.4. Application
      • 17.4.5. Route of Administration
      • 17.4.6. Age Group
      • 17.4.7. End User
    • 17.5. Egypt Gut Microbiome Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Product Type
      • 17.5.3. Technology
      • 17.5.4. Application
      • 17.5.5. Route of Administration
      • 17.5.6. Age Group
      • 17.5.7. End User
    • 17.6. Nigeria Gut Microbiome Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Product Type
      • 17.6.3. Technology
      • 17.6.4. Application
      • 17.6.5. Route of Administration
      • 17.6.6. Age Group
      • 17.6.7. End User
    • 17.7. Algeria Gut Microbiome Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Product Type
      • 17.7.3. Technology
      • 17.7.4. Application
      • 17.7.5. Route of Administration
      • 17.7.6. Age Group
      • 17.7.7. End User
    • 17.8. Rest of Africa Gut Microbiome Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Product Type
      • 17.8.3. Technology
      • 17.8.4. Application
      • 17.8.5. Route of Administration
      • 17.8.6. Age Group
      • 17.8.7. End User
  • 18. South America Gut Microbiome Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. South America Gut Microbiome Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Product Type
      • 18.3.2. Technology
      • 18.3.3. Application
      • 18.3.4. Route of Administration
      • 18.3.5. Age Group
      • 18.3.6. End User
      • 18.3.7. Country
        • 18.3.7.1. Brazil
        • 18.3.7.2. Argentina
        • 18.3.7.3. Rest of South America
    • 18.4. Brazil Gut Microbiome Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Product Type
      • 18.4.3. Technology
      • 18.4.4. Application
      • 18.4.5. Route of Administration
      • 18.4.6. Age Group
      • 18.4.7. End User
    • 18.5. Argentina Gut Microbiome Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Product Type
      • 18.5.3. Technology
      • 18.5.4. Application
      • 18.5.5. Route of Administration
      • 18.5.6. Age Group
      • 18.5.7. End User
    • 18.6. Rest of South America Gut Microbiome Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Product Type
      • 18.6.3. Technology
      • 18.6.4. Application
      • 18.6.5. Route of Administration
      • 18.6.6. Age Group
      • 18.6.7. End User
  • 19. Key Players/ Company Profile
    • 19.1. Assembly Biosciences, Inc.
      • 19.1.1. Company Details/ Overview
      • 19.1.2. Company Financials
      • 19.1.3. Key Customers and Competitors
      • 19.1.4. Business/ Industry Portfolio
      • 19.1.5. Product Portfolio/ Specification Details
      • 19.1.6. Pricing Data
      • 19.1.7. Strategic Overview
      • 19.1.8. Recent Developments
    • 19.2. Chr. Hansen Holding A/S
    • 19.3. Danone S.A.
    • 19.4. Enterome
    • 19.5. Finch Therapeutics Group, Inc.
    • 19.6. MaaT Pharma
    • 19.7. Microbiotica Ltd.
    • 19.8. Nestlé Health Science
    • 19.9. Novonesis A/S
    • 19.10. Rebiotix Inc. (a Ferring Company)
    • 19.11. Second Genome, Inc.
    • 19.12. Seres Therapeutics, Inc.
    • 19.13. Synlogic, Inc.
    • 19.14. Vedanta Biosciences, Inc.
    • 19.15. Yakult Honsha Co., Ltd.
    • 19.16. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation